Drugs / ONY-P1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00514072 | Mar 2007 → Sep 2012 | prostate cancer | Kael-GemVax Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ONY-P1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00514072 ↗ |
| Modality | Vaccine | “Biological: prostate cancer vaccine ONY-P1” NCT00514072 ↗ |